42
Views
7
CrossRef citations to date
0
Altmetric
CASE REPORT

A case of systemic sclerosis complicated by idiopathic portal hypertension: case report and literature review

, , , &
Pages 183-187 | Received 06 Feb 2006, Accepted 28 Mar 2006, Published online: 02 Jan 2014

References

  • Zakim D, Boyer T. Idiopathic portal hypertension. Hepatology. 4th ed. Philadelphia: Saunders; 2003. p. 598.
  • Subcommittee for Sderoderma Criteria of the American Rheuma-tism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scle-roderma). Arthritis Rheum 1980;23:581–90.
  • Mackworth-Young CG, Gharavi AE, Boey ML, Hughes GR. Por-tal and pulmonary hypertension in a case of systematic lupus erythematosus: possible relationship with a clotting abnormality. Eur J Ftheumatol Inflamm 1984;7:71–4.
  • De Clerck LS, Michielsen PP, Ramael MR, Janssens E, Van Maercke YM, Van Marck EA, et al. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies. J Ftheumatol 1991;18:1919–21.
  • Takahashi C, Kumagai S, Tsubata R, Sorachi K-I, Ozaki S-I, Imura H, et al. Portal hypertension associated with anticardiolipin anti-bodies in a case of systemic lupus erythematosus. Lupus 1995;4:232–5.
  • Morris JS, Htut T, Read AE. Scleroderma and portal hyperten-sion. Ann Rheum Dis 1972;31:316–8.
  • Yui S, Fukamizu A, Nishino K, Yamashita T, Yoshikawa K, Umeyama H. A case of idiopathic portal hypertension complicated by progressive systemic sclerosis (in Japanese). Hepatology 1982;23:325–31.
  • Umeyama K, Yui S, Fukamizu A, Yoshikawa K, Yamashita T. 14. Idiopathic portal hypertension associated with progressive sys-temic sclerosis. Am J Gastroenterol 1982;77: 645–8.
  • Tajima H, Inoue 0, Furukawa R, Satoh A, Mine M, Fukuda T, 15. et al. A case of progressive systemic sclerosis complicated by esophageal varices (in Japanese). Nippon Naika Gakkai Zasshi 1985;74:1108–11.
  • Nakanuma Y, Harada K. An autopsy report of a patient with 16. scleroderma who developed idiopathic portal hypertension (in Japanese). In: 2004 Reports of the Research Group on Abnormal Portal Circulation: Ministry of Health, Labour and Welfare; 1995. p. 34–7.17.
  • Kaburaki J, Kuramochi S, Fujii T, Kuwana M, Tojo T, Ikeda Y, et al. Nodular regenerative hyperplasia of the liver in a patient with systemic sclerosis. Chin Rheumatol 1996;15:613-6.18.
  • Sanchez MJ, Seco GJL, Saez-Royuela F, Llanos CMC, Perez AJC, Garcia PE, et al. Idiopathic portal hypertension, multiple focal nodular hepatic hyperplasia, the CREST syndrome and protein C deficiency (in Spanish). Rev Esp Enferm Dig 1997;89:55-9.19.
  • Asai T, Gunji T, Inamori H, Miura H, Nakajima A, Kodama T, et al. A case of Idiopathic portal hypertension complicating chronic non—suppurative destructive cholangitis and systemic sclerosis (in Japanese). Kanzo 1998;39:834–8.
  • Querfeld C, Eckes B, Huerkamp C, Krieg T, Sollberg S. Expres-sion of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma. J Dermatol Sci 1999;21: 13–22.
  • Watanabe Y, Mizukami T, Egawa T, Okamoto S, Sakauchi M, Takita T, et al. A case of progressive systemic sclerosis complicated by idiopathic portal hypertension with severe anemia. Ryumachi 1999;39:586–90.
  • Tsuneyama K, Harada K, Katayanagi K, Watanabe K, Kurumaya H, Minato H, et al. Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature. J Gastroenterol Hepatol. 2002;17:217–23.
  • Ishii M, Katada Y. Idiopathic portal hypertension in a systemic sclerosis patient heterozygous for factor V Leiden mutation. Ftheumatol Int 2003;23:44–6.
  • Robalino BD, Moodie DS. Association between primary pulmo-nary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic mani-festations. J Am Coll Cardiol 1991;17:492–8.
  • Rai T, Ohira H, Fukaya E, Abe K, Yokokawa J, Takiguchi J, et al. A case of merged idiopathic portal hypertension in the course of mixed connective tissue disease. Hepatol Res 2004;30:51–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.